Seaport Files for U.S. IPO for Neuropsychiatric Drugs Seaport filed an S-1 on Apr 11, 2026 to pursue a U.S. IPO; WHO estimates ~1bn people live with mental disorders (2019), raising stakes for clinical readouts.

Seaport Files for U.S. IPO for Neuropsychiatric Drugs: Seaport filed an S-1 on Apr 11, 2026 to pursue a U.S. IPO; WHO estimates ~1bn people live with mental disorders (2019), raising stakes for… 👈 Read full analysis #NeuropsychiatricDrugs #MentalHealth #IPO #HealthcareInvestment #ClinicalTrials